Yang Ying, Chen Fangyi, Chen Hui-Yun, Peng Hui, Hao Hua, Wang Ke-Jian
State Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.
State-Province Joint Engineering Laboratory of Marine Bioproducts and Technology, College of Ocean and Earth Sciences, Xiamen University, Xiamen, China.
Front Microbiol. 2020 Jul 24;11:1589. doi: 10.3389/fmicb.2020.01589. eCollection 2020.
Natural antimicrobial peptides (AMPs) are potential antibiotic alternatives. Marine crustaceans are thought to generate more powerful and various AMPs to protect themselves from infections caused by pathogenic microorganisms in their complex aquatic habitat, thus becoming one of the most promising sources of AMPs or other bioactive substances. In the study, a novel protein was identified as an interacting partner of male-specific AMP SCY2 in and named scyreprocin. The recombinant product of scyreprocin (rScyreprocin) was successfully expressed in . rScyreprocin exerted potent, broad-spectrum antifungal, antibacterial, and anti-biofilm activity (minimum inhibitory concentrations from 0.5 to 32 μM) through differential modes of action, including disruption of cell membrane integrity and induction of cell apoptosis, and has rapid bactericidal (in 0.5-2 h) and fungicidal (in 8-10 h) kinetics. In addition to its fungicidal activity against planktonic fungi, rScyreprocin also prevented the adhesion of fungal cells, inhibited biofilm formation, and eradicated the mature biofilms. Moreover, rScyreprocin showed a profound inhibitory effect on spore germination of spp. (minimum inhibitory concentrations from 4 to 8 μM). This peptide was not cytotoxic to murine and mammalian cells and could increase the survival rate of under the challenge of . Taken together, the novel AMP scyreprocin would be a promising alternative to antibiotics used in aquaculture and medicine.
天然抗菌肽(AMPs)是潜在的抗生素替代品。海洋甲壳类动物被认为能产生更强大、种类更多样的抗菌肽,以保护自身免受复杂水生栖息地中致病微生物感染,因此成为抗菌肽或其他生物活性物质最有前景的来源之一。在该研究中,一种新型蛋白质被鉴定为雄性特异性抗菌肽SCY2在[具体内容缺失]中的相互作用伴侣,并命名为scyreprocin。scyreprocin的重组产物(rScyreprocin)在[具体内容缺失]中成功表达。rScyreprocin通过不同作用模式发挥强大的广谱抗真菌、抗菌和抗生物膜活性(最低抑菌浓度为0.5至32μM),包括破坏细胞膜完整性和诱导细胞凋亡,并且具有快速杀菌(0.5至2小时)和杀真菌(8至10小时)动力学。除了对浮游真菌的杀真菌活性外,rScyreprocin还能防止真菌细胞黏附、抑制生物膜形成并根除成熟生物膜。此外,rScyreprocin对[具体菌种缺失]的孢子萌发显示出显著抑制作用(最低抑菌浓度为4至8μM)。这种肽对鼠类和哺乳动物细胞无细胞毒性,并且在[具体挑战缺失]的挑战下能提高[具体对象缺失]的存活率。综上所述,新型抗菌肽scyreprocin将是水产养殖和医学中使用的抗生素的有前景的替代品。